1 Aug 2026Open access
Natural Photosensitizers in Cancer Therapy: A Chemo‐Biodiversity Perspective on Light‐Activated Natural CompoundsPublisher siteChemistry & Biodiversity, Nanoplatforms for cancer theranostics
Active, last published 2026
In photodynamic therapy research studies
Isaac
Baidoo
Scholar“Research focused on Photodynamic Therapy Research Studies and adjacent fields.”
University of Johannesburg
South Africa0
H-index
0
Citations
Isaac has not officially claimed their profile. If you are Isaac, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
saac Baidoo is a researcher working on Photodynamic Therapy Research Studies. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Isaac's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Photodynamic Therapy Research Studies×3Nanoplatforms for cancer theranostics×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Johannesburg, South AfricaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works26 May 2026Open access
Comparative in vitro evaluation of chemo-phototoxic potential of green and chemically synthesised silver nanoparticles against breast cancer cell linesPublisher siteBiomedicine & Pharmacotherapy, Nanoparticles: synthesis and applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Isaac?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you